71 related articles for article (PubMed ID: 28457140)
1. Lipid Formulations and Bioconjugation Strategies for Indomethacin Therapeutic Advances.
Gliszczyńska A; Nowaczyk M
Molecules; 2021 Mar; 26(6):. PubMed ID: 33809343
[TBL] [Abstract][Full Text] [Related]
2. Introducing the 2023
Bernardes GJL; Zou P; Dai Z; Lavik E; van Hest J; Zheng G; Quinn N; MacLaughlin CM; Reineke TM
Bioconjug Chem; 2023 Feb; 34(2):279-282. PubMed ID: 36789583
[No Abstract] [Full Text] [Related]
3. The immunomodulatory function and antitumor effect of disulfiram: paving the way for novel cancer therapeutics.
Zhang S; Zong Y; Chen L; Li Q; Li Z; Meng R
Discov Oncol; 2023 Jun; 14(1):103. PubMed ID: 37326784
[TBL] [Abstract][Full Text] [Related]
4. A Comprehensive Review on Steroidal Bioconjugates as Promising Leads in Drug Discovery.
Bansal R; Suryan A
ACS Bio Med Chem Au; 2022 Aug; 2(4):340-369. PubMed ID: 37102169
[TBL] [Abstract][Full Text] [Related]
5. Antibody-Biopolymer Conjugates in Oncology: A Review.
Chavda VP; Balar PC; Teli D; Davidson M; Bojarska J; Apostolopoulos V
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985578
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of some novel hybrid molecules based on 4-thiazolidinone bearing pyridine-pyrazole scaffolds: molecular docking and molecular dynamics simulations of its major constituent onto DNA gyrase inhibition.
Desai NC; Jadeja DJ; Jethawa AM; Ahmad I; Patel H; Dave BP
Mol Divers; 2024 Apr; 28(2):693-709. PubMed ID: 36750538
[TBL] [Abstract][Full Text] [Related]
7. Enzyme-Responsive Amphiphilic Peptide Nanoparticles for Biocompatible and Efficient Drug Delivery.
Song SJ; Choi JS
Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057039
[TBL] [Abstract][Full Text] [Related]
8. An update on long-acting therapies in chronic sight-threatening eye diseases of the posterior segment: AMD, DMO, RVO, uveitis and glaucoma.
Ghanchi F; Bourne R; Downes SM; Gale R; Rennie C; Tapply I; Sivaprasad S
Eye (Lond); 2022 Jun; 36(6):1154-1167. PubMed ID: 34974541
[TBL] [Abstract][Full Text] [Related]
9. One-pot thiol-amine bioconjugation to maleimides: simultaneous stabilisation and dual functionalisation.
Wall A; Wills AG; Forte N; Bahou C; Bonin L; Nicholls K; Ma MT; Chudasama V; Baker JR
Chem Sci; 2020 Oct; 11(42):11455-11460. PubMed ID: 34094388
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles for co-delivery of osimertinib and selumetinib to overcome osimertinib-acquired resistance in non-small cell lung cancer.
Chen W; Yu D; Sun SY; Li F
Acta Biomater; 2021 Jul; 129():258-268. PubMed ID: 34048974
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Binding and Reduced Immunogenicity of Glycoconjugates Prepared via Solid-State Photoactivation of Aliphatic Diazirine Carbohydrates.
Congdon MD; Gildersleeve JC
Bioconjug Chem; 2021 Jan; 32(1):133-142. PubMed ID: 33325683
[TBL] [Abstract][Full Text] [Related]
12. Tailored therapeutics based on 1,2,3-1
Prasher P; Sharma M
Medchemcomm; 2019 Aug; 10(8):1302-1328. PubMed ID: 31534652
[TBL] [Abstract][Full Text] [Related]
13. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
[TBL] [Abstract][Full Text] [Related]
14. A Comprehensive Review on Role of Nanoparticles in Therapeutic Delivery of Medicine.
Rathor S; Bhatt DC; Aamir S; Singh SK; Kumar V
Pharm Nanotechnol; 2017; 5(4):263-275. PubMed ID: 29141578
[TBL] [Abstract][Full Text] [Related]
15. A special issue on Lipid-based delivery systems (liposomes, lipid nanoparticles, lipid matrices and medicines).
Souto EB
J Biomed Nanotechnol; 2009 Aug; 5(4):315-6. PubMed ID: 20055077
[No Abstract] [Full Text] [Related]
16. The perspectives of using unimolecular micelles in nanodrug formulation.
Wu YL; Li Z
Ther Deliv; 2019 Jun; 10(6):333-335. PubMed ID: 31140376
[No Abstract] [Full Text] [Related]
17. Delivery of oligonucleotides with lipid nanoparticles.
Wang Y; Miao L; Satterlee A; Huang L
Adv Drug Deliv Rev; 2015 Jun; 87():68-80. PubMed ID: 25733311
[TBL] [Abstract][Full Text] [Related]
18. Bioconjugate Therapeutics: Current Progress and Future Perspective.
Li F; Mahato RI
Mol Pharm; 2017 May; 14(5):1321-1324. PubMed ID: 28457140
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
